Press Releases
Wockhardt receives US FDA approval for generic version of Aricept tablets
Pharmaceutical and biotechnology major Wockhardt has received tentative approval from the United States Food & Drug Administration (US FDA) for marketing 5mg and 10mg tablets...
Press Releases
CIT/ABC acquires assets of LAB Research Inc.
Applied Biology Company (ABC), the holding company of CIT Safety & Health Research Laboratories (CIT), a leading player among European preclinical CROs, announces today the...
Press Releases
AMRI Announces Development and Commercial Supply Agreement with Parnell Manufacturing
AMRI announced that it has entered into a development and long term exclusive commercial supply agreement with Parnell Manufacturing Pty Ltd (Parnell), an Australian company...
Press Releases
Lundbeck’s partner Mochida receives approval of Lexapro in Japan
H. Lundbeck A/S announced that our partner Mochida Pharmaceutical Co., Ltd. (Mochida) has obtained approval of Lexapro® 10 mg (escitalopram) from the Japanese Ministry...
Press Releases
Amgen and UCB Announce Positive Phase 2 Results of AMG 785/CDP7851
Amgen and UCB announced positive top-line results from their Phase 2 clinical study comparing sclerostin-antibody AMG 785/CDP7851 to placebo in postmenopausal women with low bone...
Press Releases
FDA Approves Roche’s HPV Test for Identifying Women at Highest Risk for Cervical Cancer
Roche announced that the US Food and Drug Administration (FDA) has approved the cobas HPV (Human Papillomavirus) Test which identifies women at highest risk...
Press Releases
BioSante Pharmaceuticals Announces Pancreatic and Prostate Cancer Vaccine License
BioSante Pharmaceuticals, Inc. announced it has licensed its Pancreas Cancer Vaccine and Prostate Cancer Vaccine to Aduro BioTech, a clinical-stage immunotherapy company, solely for use...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.